Log In
Print
BCIQ
Print
Print this Print this
 

AB103

  Manage Alerts
Collapse Summary General Information
Company Atox Bio Inc.
DescriptionShort peptide that modulates CD28
Molecular Target CD28 receptor
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today